Effectiveness and tolerability of transdermal buprenorphine patches: a multicenter, prospective, open-label study in Asian patients with moderate to severe chronic musculoskeletal pain

被引：0
作者：
Do Heum Yoon
Seong-Il Bin
Simon Kin-Cheong Chan
Chun Kee Chung
Yong In
Hyoungmin Kim
Juan Javier Lichauco
Chi Chiu Mok
Young-Wan Moon
Tony Kwun-Tung Ng
Ester Gonzales Penserga
Dong Ah Shin
Dora You
Hanlim Moon
机构：
[1] Spine and Spinal Cord Institute,Department of Neurosurgery
[2] Yonsei University College of Medicine,Department of Orthopedic Surgery
[3] Severance Hospital,Pain Management Unit, Department of Anaesthesiology and Intensive Care
[4] Asan Medical Center,Department of Neurosurgery
[5] Prince of Wales Hospital,Department of Brain and Cognitive Science
[6] The Chinese University of Hong Kong,Department of Orthopaedic Surgery
[7] Seoul National University Hospital,Department of Orthopedic Surgery
[8] Seoul National University College of Medicine,Section of Rheumatology, Department of Medicine
[9] Seoul National University College of Natural Science,Department of Medicine
[10] Seoul St. Mary’s Hospital,Department of Orthopedic Surgery
[11] College of Medicine,Pain Management Unit, Department of Anaesthesia and Intensive Care
[12] The Catholic University of Korea,Section of Rheumatology, Department of Medicine
[13] Seoul National University Hospital,undefined
[14] Seoul National University College of Medicine,undefined
[15] St. Luke’s Medical Center,undefined
[16] Tuen Mun Hospital,undefined
[17] Samsung Medical Center,undefined
[18] Sungkyunkwan University School of Medicine,undefined
[19] Tuen Mun Hospital,undefined
[20] University of the Philippines College of Medicine-Philippine General Hospital,undefined
[21] Mundipharma Pte Ltd,undefined
来源：
BMC Musculoskeletal Disorders | / 18卷
关键词：
Transdermal buprenorphine; Asian; Chronic non-malignant pain; Musculoskeletal; Pain score; Quality of life; Sleep quality; Effectiveness; Tolerability;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 110 条
[1]  
Zhang W(2008)OARSI recommendations for the management of hip and knee osteoarthritis, part II: OARSI evidence-based, expert consensus guidelines Osteoarthr Cartil 16 137-162
[2]  
Moskowitz RW(2006)Opioids for chronic noncancer pain: a meta-analysis of effectiveness and side effects Can Med Assoc J 174 1589-1594
[3]  
Nuki G(2004)Opioids in chronic non-cancer pain: systematic review of efficacy and safety Pain 112 372-380
[4]  
Abramson S(2011)Prescription opioid abuse, pain and addiction: clinical issues and implications Drug and alcohol review 30 300-305
[5]  
Altman RD(2016)CDC guideline for prescribing opioids for chronic pain--United States, 2016 JAMA 315 1624-1645
[6]  
Arden N(2017)Guideline for opioid therapy and chronic noncancer pain CMAJ 189 E659-E666
[7]  
Furlan AD(2013)Update on prescription extended-release opioids and appropriate patient selection J Multidiscip Healthc 6 265-280
[8]  
Kalso E(2015)The unique role of transdermal buprenorphine in the global chronic pain epidemic Acta Anaesthesiol Taiwanica 53 71-76
[9]  
Edwards JE(2006)Transdermal buprenorphine in the management of persistent pain – safety aspects Ther Clin Risk Manag 2 115-125
[10]  
Moore AR(2009)Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine Eur J of Pain 13 219-230
12345678910